In response to recent meningitis B outbreaks, health authorities are considering offering a vaccine to 15-year-olds to prevent the disease. The Joint Committee on Vaccination and Immunisation (JCVI) is recommending an expanded vaccination programme for adolescents following a successful one-time vaccination campaign among university students. Government officials are now reviewing this suggestion.
Prof Wei Shen Lim, Chair of JCVI, emphasized the severity of invasive meningococcal disease and the need for preventive measures. The JCVI’s recommendation comes after collaboration with meningitis charities and input from affected individuals and families.
Meningococcal B infections can lead to life-threatening complications such as brain inflammation and sepsis, causing long-term disabilities or even death. The disease spreads through close contact, including sharing drinks, kissing, or living in communal settings.
Tragically, recent outbreaks, like the one in Kent where teenager Juliette Kenny succumbed, have underscored the urgent need for widespread vaccination. The National Pharmacy Association also noted the significant impact of meningitis outbreaks and the importance of preventive measures.
Currently, one million young people in England are eligible for a two-dose MenB vaccine program, with a focus on 17 and 18-year-olds in their final year of sixth form and students under 25 heading to college or university. Prof Shen Lim urged eligible individuals to schedule appointments for vaccination at local pharmacies before starting college or university.
It is crucial to prioritize vaccination against meningitis B to safeguard the health and well-being of young individuals, especially in light of recent outbreaks.